Major drivers for personalized medicine according to pharma companies 2015

Published by Statista Research Department, Nov 9, 2015
This statistic is based on a survey conducted during the 2nd quarter of 2015. It describes major drivers for personalized medicine according to pharmaceutical companies in Asia, Europe, and in the United States. Some 73 percent of respondents stated that a greater use of data analytics in trials will be a top driver for personalized medicine.

Major drivers for personalized medicine according to pharmaceutical companies worldwide as of 2015

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

November 2015

Region

North America, Asia, Europe

Survey time period

Q2 2015

Number of respondents

100 senior executives (CEO, CIO, Director of Strategy) in biotechnology and pharmaceuticals companies

Method of interview

Telephone interview

Supplementary notes

Original question: "Which developments do you think will be the strongest drivers for personalised medicine over the next two years?" (Please select all that apply)

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical trends in Europe "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical trends in Europe

Overview

6

Leading companies

7

Employment

6

R&D / Clinical trials / Approvals

8

Self-medication market

6

Further related statistics

4

Further Content: You might find this interesting as well

Statistics

Topics

NovartisGlobal pharmaceutical industryPharmaceutical industry in the U.S.Pfizer
All features, all contents, at all times: Learn more about our professional solutions.

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interest

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.
Menu